Loading organizations...
Loading organizations...
Pharmaceutical R&D and production for innovative drugs and APIs.
Hyperway Pharm has raised $13.8M across 1 funding round.
Hyperway Pharm has raised $13.8M in total across 1 funding round.
Hyperway Pharm has raised $13.8M in total across 1 funding round.
Hyperway Pharm's investors include Wan Lei, Ziyuan Capital.
Hyperway Pharm has raised $13.8M across 1 funding round. Most recently, it raised $13.8M Series A in April 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 22, 2024 | $13.8M Series A | Wan Lei, Ziyuan Capital |